-
O337203-100mgOlanzapine Pamoate is a new Olanzapine pamoate formulation of a second-generation antipsychotic.
-
O343812-1mgOlivetol-d9 is a precursor in various syntheses of labelled tetrahydrocannabinol.
-
O333101-100mgOlpadronic Acid is used for preparing bisphosphonic acid derivatives as anti-osteoporosis agents.
-
O401709-100mgProduct IntroductionONC206 is an analogue of TRAIL inducer ONC201 and is a selective antagonist of the D2-like dopamine receptors (DRD2/3/4) at nanomolar concentrations. ONC206 also has broad-spectrum anti-tumor activity.
-
O401709-10mgProduct IntroductionONC206 is an analogue of TRAIL inducer ONC201 and is a selective antagonist of the D2-like dopamine receptors (DRD2/3/4) at nanomolar concentrations. ONC206 also has broad-spectrum anti-tumor activity.
-
O401709-25mgProduct IntroductionONC206 is an analogue of TRAIL inducer ONC201 and is a selective antagonist of the D2-like dopamine receptors (DRD2/3/4) at nanomolar concentrations. ONC206 also has broad-spectrum anti-tumor activity.
-
O401709-50mgProduct IntroductionONC206 is an analogue of TRAIL inducer ONC201 and is a selective antagonist of the D2-like dopamine receptors (DRD2/3/4) at nanomolar concentrations. ONC206 also has broad-spectrum anti-tumor activity.
-
O401709-5mgProduct IntroductionONC206 is an analogue of TRAIL inducer ONC201 and is a selective antagonist of the D2-like dopamine receptors (DRD2/3/4) at nanomolar concentrations. ONC206 also has broad-spectrum anti-tumor activity.
-
O422018-1mlProduct IntroductionONC206 is an analogue of TRAIL inducer ONC201 and is a selective antagonist of the D2-like dopamine receptors (DRD2/3/4) at nanomolar concentrations. ONC206 also has broad-spectrum anti-tumor activity.
-
O168982-100gOrotic acid potassium salt.
-
P348980-500mgIntermediate compound obtained during the synthesis of Gabazine and other analgesic pharmaceuticals.
-
P350091-100mgp-Ethylhydratropic acid.